今开:0.3979 | 昨收:0.3851 |
最高:0.3979 | 最低:0.3311 |
涨停价:0.0 | 跌停价:0.0 |
总市值:4541951.0 |
产业链观察03-20 00:37
#药闻简讯# $Seelos Therapeutics(SEEL)$ SLS-005(静脉注射海藻糖)的肌萎缩侧索硬化症 (ALS) 研究 - 在主要和次要终点中未达到统计学意义。#临床研究失败#查看全文
产业链观察2023-09-20 20:44
#药闻简讯# 2023 年 9 月 20 日,专注于开发中枢神经系统疾病和罕见病疗法的临床阶段生物制药公司$Seelos Therapeutics(SEEL)$ SLS-002(外消旋氯胺酮鼻内注射剂)治疗重度抑郁障碍(MDD)成人急性自杀意念和行为(ASIB)的 II 期研究安慰剂对照组(第 2 部分)的最新数据显示,该疗法在多个终点上...查看全文
美股滚雪球2023-06-25 14:45
psychedelic stocks:$COMPASS Pathways(CMPS)$ 、$Mind Medicine(MNMD)$ 、$Seelos Therapeutics(SEEL)$ 、$Bright Minds(DRUG)、$180 Life(ATNF)、$GH Research(GHRS)查看全文
Seelos Therapeutics(SEEL)2023-02-10 00:57
$Seelos Therapeutics(SEEL)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-016918 Act: 34 Size: 13 KB 网页链接查看全文
Seelos Therapeutics(SEEL)03-28 20:05
$Seelos Therapeutics(SEEL)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-24-040106 Act: 34 Size: 226 KB 网页链接查看全文
Seelos Therapeutics(SEEL)03-18 18:15
$Seelos Therapeutics(SEEL)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000670 Act: 33 Size: 1 KB 网页链接查看全文
Seelos Therapeutics(SEEL)03-16 04:25
$Seelos Therapeutics(SEEL)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001104659-24-035009 Act: 33 Size: 574 KB 网页链接查看全文
Seelos Therapeutics(SEEL)03-20 04:15
$Seelos Therapeutics(SEEL)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-24-036125 Act: 34 Size: 2 MB 网页链接查看全文
Seelos Therapeutics(SEEL)03-07 19:05
$Seelos Therapeutics(SEEL)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-24-031558 Act: 33 Size: 102 KB 网页链接查看全文
Seelos Therapeutics盘前跌4.25%,报0.153美元。消息上,在Seelos Therapeutics公布了SLS-002治疗抑郁症的2期临床试验数据后,Cantor Fitzgerald将该公司的评级从“增持”下调至“中性”,同时没有... 网页链接
$Seelos Therapeutics(SEEL)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-24-040106 Act: 34 Size: 226 KB 网页链接
$Seelos Therapeutics(SEEL)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-24-036125 Act: 34 Size: 2 MB 网页链接
$Seelos Therapeutics(SEEL)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000670 Act: 33 Size: 1 KB 网页链接
$Seelos Therapeutics(SEEL)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001104659-24-035009 Act: 33 Size: 574 KB 网页链接
$Seelos Therapeutics(SEEL)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-24-031558 Act: 33 Size: 102 KB 网页链接
$Seelos Therapeutics(SEEL)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-24-031555 Act: 33 Size: 803 KB 网页链接
$Seelos Therapeutics(SEEL)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001410578-24-000140 Act: 34 Size: 9 MB 网页链接
$Seelos Therapeutics(SEEL)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-030070 Size: 5 KB 网页链接
$Seelos Therapeutics(SEEL)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001104659-24-023870 Act: 33 Size: 11 KB 网页链接
$Seelos Therapeutics(SEEL)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-24-000387 Act: 34 Size: 81 KB 网页链接